Cingulate Corp (CING): Total Asset Value of Company

Data on total assets for Cingulate Inc. (CING) on GURU.Markets, illustrating the price evolution of the quotes, stands at 23.28. Business security remains low pending FDA approval, and success depends on confirming the efficacy of the component release method. Cingulate Inc. (CING) relies on the CTRX platform, which enables pricing power through precise dosing in the treatment of ADHD. Management is betting on innovative delivery methods to simplify therapy.

Cingulate (CING) Company Total Assets: for the period 07/04/2022 - 10/27/2026

Comprehensive metric breakdowns and analytics for cingulate.com (CING)

- price and consensus price forecast:

Price Rate Chart Cingulate|CING - Price Target Chart

- market capitalization data:

Market Valuation Cingulate Inc.|CING - Enterprise Value

- book capitalization data:

Accounting Value of a Share Cingulate|CING - Book Capitalization|Market Capitalization to Book Value Ratio cingulate.com|CING - Aggregate Company Assets

- debt and liquidity data:

All Debt to Shareholders' Equity Ratio Cingulate Inc.|CING - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Cingulate|CING - Company Aggregate Debts|Debts to Book Capitalization Cingulate Inc.

Fundamental valuation:CING, Cingulate Corp

The dynamics of total capital, calculated inversely via return on assets (ROA), reflect the efficiency of resource utilization for profit generation. The growth in total assets confirms the scaling of the high-tech base of Cingulate Inc. (CING), including the automation of tablet coating lines, which, in the absence of profit growth, may signal a risk of over-investing in equipment amid a high WACC.

Competitors of Cingulate Inc. (CING)

ALKS (alkermes.com) - Company Balance Sheet Assets|Aggregate Company Assets Avadel Pharmaceuticals plc AVDL|Total Asset Value of Company atai Life Sciences NV|GH Research Corp (GHRS) - Company Total Assets|Aggregate Asset Value Mind Medicine Corp (MNMD)|Company Total Assets CMPS (COMPASS Pathways plc)|lbpharma.us - Company Total Assets|Aggregate Company Assets Bright Minds Biosciences Inc. (DRUG)|VNDA: Aggregate Asset Value|CYBN (cybin.com) - Aggregate Company Assets|Alto Neuroscience Corp (ANRO) - Cumulative Company Assets|NRXP (NRx Pharmaceuticals) - Company Total Assets|Company Total Assets Silo Pharma Inc. (SILO)|China Pharma Holdings (CPHI) - Cumulative Company Assets|Aggregate Asset Value CMND (clearmindmedicine.com)|Psyence Biomedical Limited (PBM) - Aggregate Company Assets|SciSparc Corp - Total Asset Value of Company|Aggregate Company Assets SEEL (Seelos Therapeutics)|Virpax Pharmaceuticals (VRPX) - Company Total Asset Base|Cumulative Company Assets KRTX